Real-World Evidence Market Report 2026

Real-World Evidence Market Overview

• Real-World Evidence market size has reached to $4.33 billion in 2025 • Expected to grow to $10.3 billion in 2030 at a compound annual growth rate (CAGR) of 19% • Growth Driver: Growing Demand For Precision Medicine Driving The Market Growth Due To Personalized Respiratory Care Advancements • Market Trend: Technological Advancements In Integrated Real-World Data Analytics Platforms Enhancing Patient-Centered Clinical Research And Drug Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Real-World Evidence Market?

Real-world evidence (RWE) refers to clinical insights and healthcare outcomes derived from real-world data sources such as electronic health records, insurance claims, patient registries, and wearable devices. It is used to understand treatment effectiveness, safety, and healthcare utilization in real-world settings outside controlled clinical trials. It supports evidence generation for regulatory decision-making, clinical research, and healthcare strategy by analyzing large-scale, longitudinal patient data. The main components of real-world evidence include services, data sets, and analytics platforms. Services refer to specialized support offerings that help organizations collect, analyze, and interpret real-world healthcare data for evidence generation. These solutions are deployed through cloud based and on premises models. They find application in drug development and approval, post market surveillance, market access and reimbursement, clinical and regulatory decision making, and pharmacovigilance, serving end users including pharmaceutical and biotechnology companies, healthcare providers, contract research organizations, healthcare payers, government and regulatory organizations, and medical device companies.

What Is The Real-World Evidence Market Growth Forecast?

The real-world evidence market size is expected to see rapid growth in the next few years. It will grow to $10.3 billion in 2030 at a compound annual growth rate (CAGR) of 19.0%. The growth in the forecast period can be attributed to increasing integration of AI and machine learning in real world evidence generation, rising adoption of wearable and remote monitoring devices for continuous data collection, growing demand for personalized and precision medicine insights, expansion of cloud-based healthcare analytics ecosystems, increasing use of predictive and prescriptive analytics in regulatory and reimbursement decisions. Major trends in the forecast period include increasing adoption of AI-driven real world evidence analytics platforms for clinical decision support, rising integration of wearable and remote patient monitoring data into rwe generation systems, growing use of predictive analytics for post-market surveillance and drug safety monitoring, expansion of cloud-based real world data platforms for large-scale healthcare data aggregation, increasing utilization of machine learning models for regulatory-grade evidence generation.

Global Real-World Evidence Market Segmentation

1) By Component: Services; Data Sets; Analytics Platforms 2) By Deployment Mode: Cloud Based; On Premises 3) By Application: Drug Development And Approval; Post Market Surveillance; Market Access And Reimbursement; Clinical And Regulatory Decision Making; Pharmacovigilance 4) By End User: Pharmaceutical And Biotechnology Companies; Healthcare Providers; Contract Research Organizations; Healthcare Payers; Government And Regulatory Organizations; Medical Device Companies Subsegments: 1) By Services: Consulting Services; Data Management Services; Data Collection Services; Regulatory Compliance Services; Clinical Research Support Services; Real World Data Integration Services; Evidence Generation Services 2) By Data Sets: Claims Data Sets; Electronic Health Records Data Sets; Patient Registry Data Sets; Patient Reported Outcome Data Sets; Wearable Device Data Sets; Genomic Data Sets; Pharmacy And Prescription Data Sets 3) By Analytics Platforms: Descriptive Analytics Platforms; Predictive Analytics Platforms; Prescriptive Analytics Platforms; Data Visualization Platforms; Machine Learning Based Analytics Platforms; Artificial Intelligence Driven Analytics Platforms; Real Time Analytics Platforms

What Is The Driver Of The Real-World Evidence Market?

The rising adoption of precision medicine is expected to propel the growth of the real-world evidence market going forward. Precision medicine refers to a medical approach that customizes treatment based on individual patient characteristics such as genetics, biomarkers, and disease phenotypes. The demand for precision medicine is rising due to advancements in biomarker identification and molecular diagnostics, which enable more accurate classification of respiratory conditions and targeted therapy selection. Real-World Evidence, drawn from electronic health records, registries, claims, and wearable data, enables precision medicine by showing how treatments perform across diverse populations and revealing differences in response, safety, and outcomes that help tailor therapies to individual patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. Therefore, the rising adoption of precision medicine is driving the growth of the real-world evidence industry.

Key Players In The Global Real-World Evidence Market

Major companies operating in the real-world evidence market are Optum Inc.; Oracle Corporation; IQVIA Holdings Inc.; ICON plc; Syneos Health Inc.; PPD (Thermo Fisher Scientific); Flatiron Health; Veeva Systems Inc.; Fortrea Holdings Inc.; Clarivate Plc; SAS Institute Inc.; Cegedim SA; Veradigm Inc.; Medpace Holdings Inc.; Merative L.P.; Parexel International; HealthCore Inc.; Datavant Inc.; oncertAI LLC; Komodo Health Inc.; Aetion Inc.; Truveta Inc.; HealthVerity Inc.; Evidation Health Inc.; OM1 Inc.; COTA Inc.; Cytel Inc.

Global Real-World Evidence Market Trends and Insights

Major companies operating in the real-world evidence market are focusing on developing innovative solutions, such as integrated real-world data analytics platforms, to enhance patient-centered clinical research, regulatory decision-making, and drug development efficiency. Integrated real-world data analytics platforms are advanced digital systems that aggregate and analyze diverse healthcare data sources such as electronic health records, patient-reported outcomes, wearable device data, and clinical trial datasets, enabling researchers to generate actionable insights beyond traditional controlled clinical trials. For instance, in September 2023, Maxis Clinical Sciences, a US-based life sciences services company, launched Real-World Evidence Solutions designed to support patient-centered clinical research and drug development. The solution integrates diverse real-world data sources, including patient-reported outcomes and wearable device data, to improve data quality and patient engagement. It enables applications such as personalized medicine by supporting targeted treatment strategies, regulatory submissions by strengthening evidence packages, health economics and outcomes research (HEOR) by evaluating treatment cost-effectiveness, and drug repurposing by identifying new therapeutic uses for existing medicines.

What Are Latest Mergers And Acquisitions In The Real-World Evidence Market?

In December 2023, BC Platforms AG, a Switzerland-based healthcare data management and analytics company, acquired Medexprim SAS for an undisclosed amount. With this acquisition, BC Platforms AG aimed to strengthen its global real-world data (RWD) and real-world evidence (RWE) capabilities by integrating Medexprim SAS’s multimodal clinical and imaging datasets from European hospitals, thereby expanding its ability to support precision medicine, accelerate drug development, and enhance data-driven insights for life sciences organizations. Medexprim SAS is a France-based healthcare data company that specializes in providing regulatory-grade real-world data (RWD) and real-world evidence (RWE).

Regional Outlook

North America was the largest region in the real-world evidence market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Real-World Evidence Market?

The real-world evidence market includes revenues earned by entities by providing services such as data collection and aggregation, data analytics and interpretation, observational study design, evidence generation and synthesis, regulatory consulting support, healthcare database management, and software platforms for real-world data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Real-World Evidence Market Report 2026?

The real-world evidence market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the real-world evidence industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.